Abstract
A method for the differential determination of plasma antithrombins, antithrombin III and alpha2 macroglobulin, is described. The method is based on the selective inactivation of plasma alpha2 macroglobulin by treatment with 0-1 M methylamine for 10 minutes at 37 degrees C and on the observation that antithrombin III and alpha2 macroglobulin inhibited in defibrinated plasma low concentrations of thrombin without mutual interference and according to pseudo-first order reaction. In healthy subjects antithrombin III was shown to account for about 70% of the total antithrombin activity. But in patients with liver cirrhosis, where low levels of total antithrombin activity were observed, the relative contribution of antithrombin III was found to be noticeably lower.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abildgaard U. Binding of thrombin to antithrombin III. Scand J Clin Lab Invest. 1969 Aug;24(1):23–27. doi: 10.3109/00365516909080127. [DOI] [PubMed] [Google Scholar]
- Abildgaard U., Fagerhol M. K., Egeberg O. Comparison of progressive antithrombin activity and the concentration of three thrombin inhibitors in human plasma. Scand J Clin Lab Invest. 1970 Dec;26(4):349–354. doi: 10.3109/00365517009046245. [DOI] [PubMed] [Google Scholar]
- Biggs R., Denson K. W., Akman N., Borrett R., Hadden M. Antithrombin 3, antifactor Xa and heparin. Br J Haematol. 1970 Sep;19(3):283–305. doi: 10.1111/j.1365-2141.1970.tb01627.x. [DOI] [PubMed] [Google Scholar]
- Fagerhol M. K., Abildgaard U. Immunological studies on human antithrombin 3. Influence of age, sex and use of oral contraceptives on serum concentration. Scand J Haematol. 1970;7(1):10–17. [PubMed] [Google Scholar]
- Gans H., Tan B. H. Alpha-1-antitrypsin, an inhibitor for thrombin and plasmin. Clin Chim Acta. 1967 Jul;17(1):111–117. doi: 10.1016/0009-8981(67)90104-0. [DOI] [PubMed] [Google Scholar]
- Lanchantin G. F., Plesset M. L., Friedmann J. A., Hart D. W. Dissociation of esterolytic and clotting activities of thrombin by trypsin-binding macroglobulin. Proc Soc Exp Biol Med. 1966 Feb;121(2):444–449. doi: 10.3181/00379727-121-30800. [DOI] [PubMed] [Google Scholar]
- MONKHOUSE F. C., FRANCE E. S., SEEGERS W. H. Studies on the antithrombin and heparin cofactor activities of a fraction adsorbed from plasma by aluminum hydroxide. Circ Res. 1955 Jul;3(4):397–402. doi: 10.1161/01.res.3.4.397. [DOI] [PubMed] [Google Scholar]
- Rimon A., Shamash Y., Shapiro B. The plasmin inhibitor of human plasma. IV. Its action on plasmin, trypsin, chymotrypsin, and thrombin. J Biol Chem. 1966 Nov 10;241(21):5102–5107. [PubMed] [Google Scholar]
- Rosenberg R. D., Damus P. S. The purification and mechanism of action of human antithrombin-heparin cofactor. J Biol Chem. 1973 Sep 25;248(18):6490–6505. [PubMed] [Google Scholar]
- Steinbuch M., Blatrix C. H., Josso F. Action anti-protéase de l'gamma2-macroglobuline. II. Son role d'antithrombine progressive. Rev Fr Etud Clin Biol. 1968 Feb;13(2):179–186. [PubMed] [Google Scholar]
- von Kaulla E., von Kaulla K. N. Deficiency of antithrombin 3 activity associated with hereditary thrombosis tendency. J Med. 1972;3(6):349–358. [PubMed] [Google Scholar]